The α-Klotho is known to be involved in longevity and various age-related diseases, including cognitive impairment. BACE1, an important enzyme associated with the pathological process of Alzheimer's disease (AD), serves as a biomarker for predicting changes in cognitive function. Although both proteins are closely linked to age-related cognitive function, the mechanism of their interaction remains unclear.
Objective
To identify the enzymatic digestion relation between α-Klotho and BACE1 and the specific cleavage site.
Methods
Thirty elderly and forty-five young individuals were recruited. The cleavage product was identified by Coomassie blue staining, western blot, and MALDI-TOF mass spectrometry. The concentrations of plasma proteins were measured by ELISA.
Results
A new protein product was identified after the digestion reaction. BACE1 cleaved the α-Klotho peptide 951–981 at the F-T residues. When the F-T residues were replaced with K-K, BACE1 was unable to cleave the mutant peptide. The plasma levels of α-Klotho were significantly lower in elderly participants than in young participants (p < 0.0001). However, there was no significant difference in plasma BACE1 levels between elderly and young participants (p = 0.164). In elderly adults, there was a significant positive correlation between plasma BACE1 and α-Klotho protein levels (p = 0.009, r = 0.469), while this correlation was not observed in young adults (p = 0.170, r = −0.208).
Conclusions
The anti-aging protein α-Klotho is a substrate of BACE1 with a specific cleavage site at F-T. The BACE1/α-Klotho pathway may serve as a common axis for age-related cognitive decline.
Kuro-oMMatsumuraYAizawaH, et al.Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature1997; 390: 45–51.
2.
KurosuHYamamotoMClarkJD, et al.Suppression of aging in mice by the hormone Klotho. Science2005; 309: 1829–1833.
3.
MasudaHChikudaHSugaT, et al.Regulation of multiple ageing-like phenotypes by inducible klotho gene expression in klotho mutant mice. Mech Ageing Dev2005; 126: 1274–1283.
4.
KimYKimJHNamYJ, et al.Klotho is a genetic risk factor for ischemic stroke caused by cardioembolism in Korean females. Neurosci Lett2006; 407: 189–194.
5.
ShimoyamaYNishioKHamajimaN, et al.KLOTHO Gene polymorphisms G-395A and C1818T are associated with lipid and glucose metabolism, bone mineral density and systolic blood pressure in Japanese healthy subjects. Clin Chim Acta2009; 406: 134–138.
6.
MullinBHWilsonSGIslamFMA, et al.Klotho gene polymorphisms are associated with osteocalcin levels but not bone density of aged postmenopausal women. Calcif Tissue Int2005; 77: 145–151.
7.
TelciDDoganAUOzbekE, et al.KLOTHO Gene polymorphism of G395A is associated with kidney stones. Am J Nephrol2011; 33: 337–343.
8.
WolfILaitmanYRubinekT, et al.Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin. Oncogene2010; 29: 26–33.
9.
AbuliziPZhouXHKeyimuK, et al.Correlation between KLOTHO gene and mild cognitive impairment in the Uygur and Han populations of Xinjiang. Oncotarget2017; 43: 75174–75185.
10.
HaoQDingXGaoL, et al.G-395A polymorphism in the promoter region of the KLOTHO gene associates with reduced cognitive impairment among the oldest old. Age (Dordr)2016; 38: 7.
11.
InvidiaLSalvioliSAltiliaS, et al.The frequency of Klotho KL-VS polymorphism in a large Italian population, from young subjects to centenarians, suggests the presence of specific time windows for its effect. Biogerontology2010; 11: 67–73.
12.
ArkingDEKrebsovaAMacekMSr, et al.Association of human aging with a functional variant of klotho. Proc Natl Acad Sci U S A2002; 99: 856–861.
13.
GermanDCKhobahyIPastorJ, et al.Nuclear localization of Klotho in brain: an anti-aging protein. Neurobiol Aging2012; 33: 1483e1425–1430.
14.
ChenCDTungTYLiangJ, et al.Identification of cleavage sites leading to the shed form of the anti-aging protein klotho. Biochemistry2014; 53: 5579–5587.
15.
MatsumuraYAizawaHShiraki-IidaT, et al.Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. Biochem Biophys Res Commun1998; 242: 626–630.
16.
KurosuHOgawaYMiyoshiM, et al.Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem2006; 281: 6120–6123.
17.
UrakawaIYamazakiYShimadaT, et al.Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature2006; 444: 770–774.
18.
Kuro-oM. Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism. Curr Opin Nephrol Hypertens2006; 15: 437–441.
19.
ImuraAIwanoATohyamaO, et al.Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane. FEBS Lett2004; 565: 143–147.
20.
HuMCShiMZhangJ, et al.Renal production, uptake, and handling of circulating alphaKlotho. J Am Soc Nephrol2016; 27: 79–90.
21.
HsiehCCKuro-oMRosenblattKP, et al.The ASK1-signalosome regulates p38 MAPK activity in response to levels of endogenous oxidative stress in the Klotho mouse models of aging. Aging (Albany NY)2010; 2: 597–611.
22.
Kuro-oM. Klotho and aging. Biochim Biophys Acta2009; 1790: 1049–1058.
23.
YamamotoMClarkJDPastorJV, et al.Regulation of oxidative stress by the anti-aging hormone klotho. J Biol Chem2005; 280: 38029–38034.
24.
BlochLSineshchekovaOReichenbachD, et al.Klotho is a substrate for alpha-, beta- and gamma-secretase. FEBS Lett2009; 583: 3221–3224.
25.
HemmingMLEliasJEGygiSP, et al.Identification of beta-secretase (BACE1) substrates using quantitative proteomics. PLoS One2009; 4: e8477.
26.
KuhnPHKoroniakKHoglS, et al.Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons. EMBO J2012; 31: 3157–3168.
27.
ZhouLBaraoSLagaM, et al.The neural cell adhesion molecules L1 and CHL1 are cleaved by BACE1 protease in vivo. J Biol Chemy2012; 287: 25927–25940.
28.
HoglSvan BebberFDislichB, et al.Label-free quantitative analysis of the membrane proteome of Bace1 protease knock-out zebrafish brains. Proteomics2013; 13: 1519–1527.
29.
DislichBWohlrabFBachhuberT, et al.Label-free quantitative proteomics of mouse cerebrospinal fluid detects beta-site APP cleaving enzyme (BACE1) protease substrates in vivo. Mol Cell Proteomics2015; 14: 2550–2563.
30.
GuixFXSartorioCLIll-RagaG. BACE1 Translation: at the crossroads between Alzheimer's disease neurodegeneration and memory consolidation. J Alzheimers Dis Rep2019; 3: 113–148.
31.
ShenYWangHSunQ, et al.Increased plasma beta-secretase 1 may predict conversion to Alzheimer's disease dementia in individuals with mild cognitive impairment. Biol Psychiatry2018; 83: 447–455.
32.
ZhongZEwersMTeipelS, et al.Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment. Arch Gen Psychiatry2007; 64: 718–726.
33.
RabeSReichwaldJAmmaturoD, et al.The Swedish APP mutation alters the effect of genetically reduced BACE1 expression on the APP processing. J Neurochem2011; 119: 231–239.
34.
HuXHeWDiaconuC, et al.Genetic deletion of BACE1 in mice affects remyelination of sciatic nerves. FASEB J2008; 22: 2970–2980.
35.
FleckDvan BebberFColomboA, et al.Dual cleavage of neuregulin 1 type III by BACE1 and ADAM17 liberates its EGF-like domain and allows paracrine signaling. J Neurosci2013; 33: 7856–7869.
36.
HuXHeWLuoX, et al.BACE1 Regulates hippocampal astrogenesis via the Jagged1-Notch pathway. Cell Rep2013; 4: 40–49.
37.
HuXHouHBastianC, et al.BACE1 Regulates the proliferation and cellular functions of Schwann cells. Glia2017; 65: 712–726.
38.
KuhnPHMarjauxEImhofA, et al.Regulated intramembrane proteolysis of the interleukin-1 receptor II by alpha-, beta-, and gamma-secretase. J Biol Chem2007; 282: 11982–11995.
39.
HeWHuJXiaY, et al.beta-site amyloid precursor protein cleaving enzyme 1(BACE1) regulates Notch signaling by controlling the cleavage of Jagged 1 (Jag1) and Jagged 2 (Jag2) proteins. J Biol Chem2014; 289: 20630–20637.
40.
GersbacherMTKimDYBhattacharyyaR, et al.Identification of BACE1 cleavage sites in human voltage-gated sodium channel beta 2 subunit. Mol Neurodegener2010; 5: 61.
41.
LichtenthalerSFDominguezDIWestmeyerGG, et al.The cell adhesion protein P-selectin glycoprotein ligand-1 is a substrate for the aspartyl protease BACE1. J Biol Chem2003; 278: 48713–48719.
42.
PigoniMWanngrenJKuhnPH, et al.Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons. Mol Neurodegener2016; 11: 67.
43.
KitazumeSTachidaYOkaR, et al.Characterization of alpha 2,6-sialyltransferase cleavage by Alzheimer's beta-secretase (BACE1). J Biol Chem2003; 278: 14865–14871.
44.
SembaRDMoghekarARHuJ, et al.Klotho in the cerebrospinal fluid of adults with and without Alzheimer's disease. Neurosci Lett2014; 558: 37–40.
45.
LiuHJFergussonMMCastilhoRM, et al.Augmented Wnt signaling in a mammalian model of accelerated aging. Science2007; 317: 803–806.
46.
DoiSZouYTogaoO, et al.Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice. J Biol Chem2011; 286: 8655–8665.
47.
FungTYIyaswamyASreenivasmurthySG, et al.Klotho an autophagy stimulator as a potential therapeutic target for Alzheimer's disease: a review. Biomedicines2022; 10: 705.
48.
OlausonHMenckeRHillebrandsJL, et al.Tissue expression and source of circulating alphaKlotho. Bone2017; 100: 19–35.
49.
TaylorHAPrzemylskaLClavaneEM, et al.BACE1: more than just a beta-secretase. Obes Rev2022; 23: e13430.
50.
Gruninger-LeitchFSchlatterDKungE, et al.Substrate and inhibitor profile of BACE (beta-secretase) and comparison with other mammalian aspartic proteases. J Biol Chem2002; 277: 4687–4693.
51.
BaoHShenY. Unmasking BACE1 in aging and age-related diseases. Trends Mol Med2023; 29: 99–111.
52.
ZengCYYangTTZhouHJ, et al.Lentiviral vector-mediated overexpression of Klotho in the brain improves Alzheimer's disease-like pathology and cognitive deficits in mice. Neurobiol Aging2019; 78: 18–28.
53.
ZhaoYZengCYLiXH, et al.Klotho overexpression improves amyloid-beta clearance and cognition in the APP/PS1 mouse model of Alzheimer's disease. Aging Cell2020: e13239.
54.
ZhuLSteinLRKimD, et al.Klotho controls the brain-immune system interface in the choroid plexus. Proc Natl Acad Sci U S A2018; 115: E11388–E11396.
55.
ChenKSunZ. Autophagy plays a critical role in Klotho gene deficiency-induced arterial stiffening and hypertension. J Mol Med2019; 97: 1615–1625.
56.
NelsonPTHeadESchmittFA, et al.Alzheimer's disease is not “brain aging”: neuropathological, genetic, and epidemiological human studies. Acta Neuropathol2011; 121: 571–587.
YokoyamaJSSturmVEBonhamLW, et al.Variation in longevity gene KLOTHO is associated with greater cortical volumes. Ann Clin Transl Neurol2015; 2: 215–230.
59.
ShardellMSembaRDRosanoC, et al.Plasma Klotho and cognitive decline in older adults: findings from the InCHIANTI study. J Gerontol A Biol Sci Med Sci2016; 71: 677–682.
60.
BromboGBonettiFOrtolaniB, et al.Lower plasma klotho concentrations are associated with vascular dementia but not late-onset Alzheimer's disease. Gerontology2018; 64: 414–421.
